ArticlePharmaceuticals (Basel, Switzerland)2022

Bisimidazolium Salt Glycosyltransferase Inhibitors Suppress Hepatocellular Carcinoma Progression In Vitro and In Vivo.

Xue Luan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.